Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH awards $42 million to expand Human Microbiome Project

This article was originally published in The Gray Sheet

Executive Summary

National Institutes of Health announces June 23 new funding that will help researchers track the genomes, or DNA, of microscopic organisms that live in or on the human body. Studies will use samples collected from seven areas of the body: the digestive tract, mouth, skin, nose, blood, vagina and male urethra. Related disease states under investigation include obesity, sexually transmitted diseases, psoriasis and Crohn's disease. "This effort will accelerate our understanding of how our bodies and microorganisms interact to influence health and disease," NIH explains. The agency launched the five-year Human Microbiome Project in 2007 as part of its Common Fund's Roadmap for Medical Research. Funds will go to investigators in St. Louis; Rockville and Bethesda, Md.; New York; Richmond, Va.; Indianapolis; Los Angeles; Houston; Philadelphia; and Ann Arbor, Mich
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel